Stemtech Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons :

Growth Rates ▼

Select the Ratio:

None▼

Growth Rates ▼

None▼

Download as CSV

STEK Revenue Growth Rate Comparisons	Company	Industry	Sector	S&P 500
Y / Y Revenue Growth (Q3 MRQ)	-35.71 %	10.36 %	7.43 %	7.96 %
Q / Q Revenue Growth (Q3 MRQ)	22.12 %	4.78 %	2.92 %	4.62 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM)	-41.67 %	9.89 %	6.85 %	%
Sequential Revenue Growth (for 12 months ending Q3 TTM)	-13.11 %	2.54 %	1.86 %	1.99 %
Revenue 5 Year Average Growth	-	12.31 %	10.02 %	7.56 %

STEK's Growth Comparisons in III. Quarter 2025

Stemtech's Revenue were slashed by -35.71% in the third quarter 2025 from the same quarter a year ago, to $ 1 millions, while sales in thePharmacy Services & Retail Drugstore industry grew by 10.36%, and underperformed the 7.43% Revenue growth in the Retail sector. Comparing the third quarter, sales Stemtech Corporation was trailing overall market not just Pharmacy Services & Retail Drugstore industry.

Company's sequential top-line increase was 22.12% from the second quarter. Average annual sales rise for Stemtech is %, while S & P 500's average yearly sales growth is 7.56% over the five years, including only Businesses with the third quarter 2025 Results.

STEK Growth Rates by Company's Segments

Segment Name		Y / Y	Sequential
Total		-	22.12 %

Growth Rates of STEK's Income in the third quarter 2025

STEK Operating Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Operating Income Change (Q3 MRQ)	-	-	-4.91 %	15.18 %
Sequential Operating Income Change (Q3 MRQ)	-	-	-13.51 %	7.5 %
Y / Y Operating Income Growth (Q3 TTM)	-	-8.41 %	8.2 %	6.78 %
Sequential Operating Income Growth (Q3 TTM)	-	-16.41 %	-1.15 %	3.69 %
Operating Income 5 Year Avg. Change	-	-38.02 %	9.93 %	9.14 %

Income from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ)	-	-	20.17 %	19.52 %
Sequential Income from Cont. Ops. Change (Q3 MRQ)	-	-	-2.59 %	2.98 %
Y / Y Income from Cont. Ops. Change (Q3 TTM)	-	-20.12 %	24.01 %	14.87 %
Sequential Income from Cont. Ops. Change (Q3 TTM)	-	-28.74 %	4.58 %	4.59 %
Income from Cont. Ops. 5 Year Avg. Change	-	-	13.48 %	9.13 %

STEK Net Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Net Income Growth (Q3 MRQ)	-	-	20.14 %	18.78 %
Q / Q Net Income Growth (Q3 MRQ)	-	-	-2.74 %	3.06 %
Y / Y Net Income Change (Q3 TTM)	-	-20.12 %	24.33 %	15.72 %
Sequential Net Income Change (Q3 TTM)	-	-28.74 %	4.56 %	4.42 %
Net Income 5 Year Avg. Growth	-	-	12.89 %	8.69 %

STEK's EPS Growth Rates

EPS from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ)	-	-	20.17 %	19.52 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ)	-	-	-2.59 %	2.98 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM)	-	66.73 %	-	-
Sequential EPS from Cont. Ops. Change (Q3 TTM)	-	10 %	-	-47.95 %
EPS from Cont. Ops. 5 Year Avg. Growth	-	-	13.48 %	9.13 %

STEK EPS Net Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS Net Growth (Q3 MRQ)	-	-	20.14 %	9.13 %
Q / Q EPS Net Growth (Q3 MRQ)	-	-	-2.74 %	3.06 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM)	-	67.36 %	-	-66.91 %
Sequential EPS Net Change (for 12 months ending Q3 TTM)	-	9.95 %	-	-47.94 %
EPS Net 5 Year Avg. Change	-	-	12.89 %	8.69 %

Stemtech reported bottom-line of $ -0.01 in the third quarter, compare to $ -0.01 in the same quarter a year ago. Pharmacy Services & Retail Drugstore industry grew by 10.36%, while Retail sector increased by 20.14%, and overall market improved by 18.78%.

The company's sequential bottom-line increase was 22.12% from the second quarter. Average annual income per share rise for Stemtech is %, while S & P 500's average yearly income per share growth is 8.69% over the five years, including only Businesses with the third quarter 2025 earnings results.

STEK Cash Flow Growth Rates

Free Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ)	-	758.5 %	32.67 %	76.78 %
Sequential Free Cash Flow Change (Q3 MRQ)	-66.68 %	171.71 %	-3.36 %	27.6 %
Y / Y Free Cash Flow Change (Q3 TTM)	-	50.73 %	16.46 %	19.84 %
Sequential Free Cash Flow Change (Q3 TTM)	-	28.44 %	7.16 %	13.42 %
Free Cash Flow 5 Year Avg. Change	-	-4.81 %	5.71 %	8.27 %

Net Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ)	-	-	674.32 %	-
Sequential Net Cash Flow Change (Q3 MRQ)	-	-	-	-
Y / Y Net Cash Flow Change (Q3 TTM)	-	-	-64.79 %	-
Sequential Net Cash Flow Change (Q3 TTM)	-	-	-	-
Net Cash Flow 5 Year Avg. Change	-	14.19 %	22.75 %	0.42 %

Capital Expenditures	Company	Industry	Sector	S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ)	-	6.44 %	34.6 %	22.55 %
Sequential Capital Expenditures Change (Q3 MRQ)	-	3.49 %	9.15 %	8.68 %
Y / Y Capital Expenditures Change (Q3 TTM)	-	2.4 %	35.73 %	23.2 %
Sequential Capital Expenditures Change (Q3 TTM)	-	1.72 %	8.18 %	5.37 %
Capital Expenditures 5 Year Avg. Change	-	2.92 %	14.5 %	7.58 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.